Archive for September, 2010



Avoid This Multibillion-Dollar Market

Thursday 30 September 2010 @ 4:04 pm

It’s just too crowded.




Tanezumab Alleviates Osteoarthritis Pain So Well That Some Patients Overuse Their Diseased Joints

Thursday 30 September 2010 @ 1:22 pm

After halting studies on tanezumab, a drug that is extremely good at relieving pain and improving function in patients with moderate to severe osteoarthritis, a small phase II clinical trial has reported just a few slight side effects, and considerable improvement in the condition of patients. Details of the 16-week trial have been published in the New England Journal of Medicine…




Bye Bye Lyrica, hello Vain in downtown Orlando

Thursday 30 September 2010 @ 12:06 pm

Another blow to alternative rock in Orlando happened this week when Lyrica was bought out by the owners of Deko’s and Scoop. Anyone familiar with the UCF nightclubs know alternative rock will not be a part of their lineup at the new club that will be called Vain.




Tanezumab Found To Reduce Osteoarthritis Knee Pain In Phase II Study

Thursday 30 September 2010 @ 11:23 am

Just months after a pharmaceutical company halted studies of tanezumab, a drug used in reducing pain and improving function in people with moderate-to-severe osteoarthritis of the knee, the results of a small, phase II clinical trial found only a few minor side effects and substantial improvement in patient conditions. The results of the 16-week study are published in the Sept. 30 issue of The …




NIH awards three grants to explore novel treatment strategies for muscular dystrophy

Thursday 30 September 2010 @ 4:32 am

Three grants totaling more than $4.5 million, from agencies of the National Institutes of Health, will be used to explore novel treatment strategies for muscular dystrophy.




Study finds tanezumab reduces osteoarthritis knee pain

Wednesday 29 September 2010 @ 5:47 pm

Just months after a pharmaceutical company halted studies of tanezumab, a drug used in reducing pain and improving function in people with moderate-to-severe osteoarthritis of the knee, the results of a small, phase II clinical trial found only a few minor side effects and substantial improvement in patient conditions.




Phase II study finds tanezumab reduces osteoarthritis knee pain

Wednesday 29 September 2010 @ 5:32 pm

Only two months after a pharmaceutical company halted studies of tanezumab, a drug used in reducing pain and improving function in people with moderate-to-severe osteoarthritis of the knee.




Doctor keeps running during cancer treatment

Wednesday 29 September 2010 @ 3:55 pm

Joe Truong wore a chemotherapy pump while running in a halfmarathon in the spring.




Va. Beach man pleads guilty in prescription patch overdose case

Wednesday 29 September 2010 @ 3:19 pm

VIRGINIA BEACH — A Va. Beach man pleaded guilty Wednesday to drug conspiracy charges for supplying pain killer patches used by two friends who overdosed and died. Jason Coker, 31, gave the patches to his former roommate, Nabil Butros, who gave them to Barry Sullivan, 18, and David Ellison, 19. The teen were found dead in January from a combination of alcohol, Xanax and Fentanyl, which comes in …




Florida Likely To Seek Waiver On Medical Loss Ratio; Ariz. Cuts Back Medicaid Benefits

Wednesday 29 September 2010 @ 12:26 pm

The Hill Healthwatch: “Florida’s 14-member insurance advisory board has unanimously passed a resolution to seek a waiver from the health law’s medical loss ratio. An official with the Florida Office of Insurance Regulation tells The Hill that the board’s vote means it’s a ‘done deal’ that the state will formally seek some kind of waiver but the board is gathering public input through Oct. 8. The …




«« Previous Posts